Standard Biotools Inc (LAB) — Cash Flow-to-Debt Ratio
Standard Biotools Inc (LAB) has a Cash Flow-to-Debt Ratio of -0.60x as of March 2026, meaning its operating cash flow of $-46.60 Million could theoretically repay -1% of its total liabilities ($77.99 Million) in one year. See Standard Biotools Inc (LAB) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Standard Biotools Inc Cash Flow-to-Debt Ratio (2006–2025)
Historical debt coverage capacity for Standard Biotools Inc across 20 annual periods. Also explore LAB net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Standard Biotools Inc (2006–2025)
Year-by-year debt coverage analysis for Standard Biotools Inc. For market capitalisation and broader financial context, see LAB company net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | $-74.35 Million | $143.46 Million | ▲ +49.2% |
| 2024 | -1.02x | $-143.45 Million | $140.62 Million | ▼ -1010.3% |
| 2023 | -0.09x | $-43.29 Million | $471.12 Million | ▲ +51.5% |
| 2022 | -0.19x | $-89.37 Million | $471.78 Million | ▲ +22.3% |
| 2021 | -0.24x | $-44.06 Million | $180.62 Million | ▼ -193.8% |
| 2020 | -0.08x | $-15.42 Million | $185.71 Million | ▲ +73.8% |
| 2019 | -0.32x | $-35.21 Million | $111.20 Million | ▼ -190.9% |
| 2018 | -0.11x | $-25.20 Million | $231.53 Million | ▼ -15.8% |
| 2017 | -0.09x | $-24.10 Million | $256.42 Million | ▲ +39.1% |
| 2016 | -0.15x | $-39.10 Million | $253.16 Million | ▼ -14.0% |
| 2015 | -0.14x | $-34.70 Million | $256.16 Million | ▼ -54.0% |
| 2014 | -0.09x | $-22.62 Million | $257.14 Million | ▼ -9.5% |
| 2013 | -0.08x | $-1.59 Million | $19.80 Million | ▲ +94.0% |
| 2012 | -1.34x | $-17.48 Million | $13.07 Million | ▼ -70.9% |
| 2011 | -0.78x | $-17.54 Million | $22.43 Million | ▼ -1354.2% |
| 2010 | -0.05x | $-11.51 Million | $213.97 Million | ▲ +43.3% |
| 2009 | -0.09x | $-19.51 Million | $205.77 Million | ▲ +37.0% |
| 2008 | -0.15x | $-28.72 Million | $190.69 Million | ▼ -28.1% |
| 2007 | -0.12x | $-21.76 Million | $185.11 Million | ▲ +24.8% |
| 2006 | -0.16x | $-22.31 Million | $142.66 Million | — |